These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 8762812)
1. In vivo effects of various therapies on complement-sensitive erythrocytes in paroxysmal nocturnal hemoglobinuria. Shichishima T; Saitoh Y; Noji H; Terasawa T; Maruyama Y Int J Hematol; 1996 Jun; 63(4):291-302. PubMed ID: 8762812 [TBL] [Abstract][Full Text] [Related]
2. Aurin tricarboxylic acid protects against red blood cell hemolysis in patients with paroxysmal nocturnal hemoglobinemia. Lee M; Narayanan S; McGeer EG; McGeer PL PLoS One; 2014; 9(1):e87316. PubMed ID: 24489894 [TBL] [Abstract][Full Text] [Related]
3. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Hall SE; Rosse WF Blood; 1996 Jun; 87(12):5332-40. PubMed ID: 8652849 [TBL] [Abstract][Full Text] [Related]
4. The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis. Rosse WF; Hoffman S; Campbell M; Borowitz M; Moore JO; Parker CJ Br J Haematol; 1991 Sep; 79(1):99-107. PubMed ID: 1716964 [TBL] [Abstract][Full Text] [Related]
5. Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria. Holguin MH; Wilcox LA; Bernshaw NJ; Rosse WF; Parker CJ J Clin Invest; 1989 Nov; 84(5):1387-94. PubMed ID: 2478585 [TBL] [Abstract][Full Text] [Related]
6. Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes. Medof ME; Gottlieb A; Kinoshita T; Hall S; Silber R; Nussenzweig V; Rosse WF J Clin Invest; 1987 Jul; 80(1):165-74. PubMed ID: 2439544 [TBL] [Abstract][Full Text] [Related]
7. The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment. Risitano AM; Notaro R; Pascariello C; Sica M; del Vecchio L; Horvath CJ; Fridkis-Hareli M; Selleri C; Lindorfer MA; Taylor RP; Luzzatto L; Holers VM Blood; 2012 Jun; 119(26):6307-16. PubMed ID: 22577173 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF. Shichishima T; Terasawa T; Saitoh Y; Hashimoto C; Ohto H; Maruyama Y Br J Haematol; 1993 Oct; 85(2):378-86. PubMed ID: 7506570 [TBL] [Abstract][Full Text] [Related]
10. Investigation of the survival of paroxysmal nocturnal hemoglobinuria red cells through the immunophenotyping of reticulocytes. Navenot JM; Muller JY; Blanchard D Transfusion; 1998 Apr; 38(4):337-42. PubMed ID: 9595015 [TBL] [Abstract][Full Text] [Related]
11. Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum. Wilcox LA; Ezzell JL; Bernshaw NJ; Parker CJ Blood; 1991 Aug; 78(3):820-9. PubMed ID: 1713516 [TBL] [Abstract][Full Text] [Related]
12. Longer in vivo survival of CD59- and decay-accelerating factor-almost normal positive and partly positive erythrocytes in paroxysmal nocturnal hemoglobinuria as compared with negative erythrocytes: a demonstration by differential centrifugation and flow cytometry. Fujioka S; Yamada T Blood; 1992 Apr; 79(7):1842-5. PubMed ID: 1373090 [TBL] [Abstract][Full Text] [Related]
13. Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies. Risitano AM Adv Exp Med Biol; 2013; 735():155-72. PubMed ID: 23402025 [TBL] [Abstract][Full Text] [Related]
17. Complement sensitivity of erythrocytes in a patient with inherited complete deficiency of CD59 or with the Inab phenotype. Shichishima T; Saitoh Y; Terasawa T; Noji H; Kai T; Maruyama Y Br J Haematol; 1999 Feb; 104(2):303-6. PubMed ID: 10050712 [TBL] [Abstract][Full Text] [Related]
18. PNH revisited: Clinical profile, laboratory diagnosis and follow-up. Gupta PK; Charan VD; Kumar H Indian J Pathol Microbiol; 2009; 52(1):38-41. PubMed ID: 19136777 [TBL] [Abstract][Full Text] [Related]
19. Expression of cryptantigen Th on paroxysmal nocturnal hemoglobinuria erythrocytes in association with a hemolytic exacerbation. Nakakuma H; Hidaka M; Nagakura S; Nishimura Y; Iwamoto N; Horikawa K; Kawaguchi T; Kagimoto T; Takatsuki K J Clin Invest; 1995 Jul; 96(1):201-6. PubMed ID: 7542278 [TBL] [Abstract][Full Text] [Related]
20. Changes in electrophoretic mobility pattern of erythrocytes in patients with paroxysmal nocturnal hemoglobinuria. Hayashi H; Fujii M; Yoshikumi C; Kawai Y; Watanabe N; Watanabe K; Fusama M; Shishido H J Clin Lab Immunol; 1987 Jun; 23(2):77-81. PubMed ID: 3625755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]